Insider · CIK 0001803375
Dwight Moxie
Files at RVNC (Revance Therapeutics, Inc.). First filing Mar 19, 2024, latest Mar 19, 2024.
In brief
Dwight Moxie files SEC Form 4 as officer at RVNC (Revance Therapeutics, Inc.). Since Mar 19, 2024, Dwight Moxie has reported 0 open-market buys worth $0 and 1 open-market sell worth $41k, the latest filed on Mar 19, 2024.
A track record needs three past buys with six months of prices behind them; Dwight Moxie has 0, so none is measured yet.
The newest scored trade: sold $41k of RVNC on Mar 18, 2024, filed Mar 19, 2024, scored 36 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Revance Therapeutics, Inc. | $41k 8,125 shares | -6% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 18, 2024 | RVNC Revance Therapeutics, Inc. | 8,500 0.01% of outstanding | $47k | Mar 15, 2024 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | RVNC Revance Therapeutics, Inc. | FTax withholding Common Stock | -3,269 | $5.31 | $17k | 145,940 | Mar 19, 2024 |
| Mar 18, 2024 | RVNC Revance Therapeutics, Inc. | SOpen-market sale Common Stock | -8,125 | $5.04 | $41k | 137,815 | Mar 19, 2024 |
| Feb 29, 2024 | RVNC Revance Therapeutics, Inc. | AGrant or award Common Stock | +15,143 | $0.00 | $0 | 149,209 | Mar 4, 2024 |
| Jan 31, 2024 | RVNC Revance Therapeutics, Inc. | AGrant or award Common Stock | +90,000 | $0.00 | $0 | 134,066 | Feb 2, 2024 |
| Jan 31, 2024 | RVNC Revance Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +135,000 | $0.00 | $0 | 135,000 | Feb 2, 2024 |
Questions about Dwight Moxie
Answered from the filings on this page, as of the latest one.
Is Dwight Moxie buying or selling?
Not in the last 12 months. Dwight Moxie's latest open-market trade on SEC Form 4 was sold $41k of RVNC on Mar 18, 2024.
How did Dwight Moxie's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dwight Moxie has 0.
Where does Dwight Moxie file Form 4?
Dwight Moxie has filed Form 4 at RVNC (Revance Therapeutics, Inc.) as CLO & GC. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.